Drug Profile
AZD 8677
Alternative Names: AZD8677Latest Information Update: 02 Feb 2007
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus; Lipid metabolism disorders
Most Recent Events
- 01 Feb 2007 Discontinued - Phase-I for Diabetes mellitus in Sweden (unspecified route)
- 01 Feb 2007 Discontinued - Phase-I for Lipid metabolism disorders in Sweden (unspecified route)
- 28 Jul 2005 Phase-I clinical trials in Diabetes mellitus in Sweden (unspecified route)